» Articles » PMID: 29210203

The Effects of the Attributable Fraction and the Duration of Symptoms on Burden Estimates of Influenza-associated Respiratory Illnesses in a High HIV Prevalence Setting, South Africa, 2013-2015

Abstract

Background: The attributable fraction of influenza virus detection to illness (INF-AF) and the duration of symptoms as a surveillance inclusion criterion could potentially have substantial effects on influenza disease burden estimates.

Methods: We estimated rates of influenza-associated influenza-like illness (ILI) and severe acute (SARI-10) or chronic (SCRI-10) respiratory illness (using a symptom duration cutoff of ≤10 days) among HIV-infected and HIV-uninfected patients attending 3 hospitals and 2 affiliated clinics in South Africa during 2013-2015. We calculated the unadjusted and INF-AF-adjusted rates and relative risk (RR) due to HIV infection. Rates were expressed per 100 000 population.

Results: The estimated mean annual unadjusted rates of influenza-associated illness were 1467.7, 50.3, and 27.4 among patients with ILI, SARI-10, and SCRI-10, respectively. After adjusting for the INF-AF, the percent reduction in the estimated rates was 8.9% (rate: 1336.9), 11.0% (rate: 44.8), and 16.3% (rate: 22.9) among patients with ILI, SARI-10, and SCRI-10, respectively. HIV-infected compared to HIV-uninfected individuals experienced a 2.3 (95% CI: 2.2-2.4)-, 9.7 (95% CI: 8.0-11.8)-, and 10.0 (95% CI: 7.9-12.7)-fold increased risk of influenza-associated illness among patients with ILI, SARI-10, and SCRI-10, respectively. Overall 34% of the estimated influenza-associated hospitalizations had symptom duration of >10 days; 8% and 44% among individuals aged <5 and ≥5 years, respectively.

Conclusion: The marginal differences between unadjusted and INF-AF-adjusted rates are unlikely to affect policies on prioritization of interventions. HIV-infected individuals experienced an increased risk of influenza-associated illness and may benefit more from annual influenza immunization. The use of a symptom duration cutoff of ≤10 days may underestimate influenza-associated disease burden, especially in older individuals.

Citing Articles

The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing.

Kittikraisak W, Tinoco Y, Levine M, Mott J, Kanjanapattanakul W, Munayco C Int J Infect Dis. 2024; 149():107264.

PMID: 39426491 PMC: 11710853. DOI: 10.1016/j.ijid.2024.107264.


Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus.

Tortellini E, Fosso Ngangue Y, Dominelli F, Guardiani M, Falvino C, Mengoni F Viruses. 2023; 15(9).

PMID: 37766251 PMC: 10534440. DOI: 10.3390/v15091844.


The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016.

Moyes J, Tempia S, Walaza S, McMorrow M, Cohen A, Treurnicht F Int J Infect Dis. 2023; 134:71-77.

PMID: 37211271 PMC: 10675839. DOI: 10.1016/j.ijid.2023.05.009.


The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016.

Moyes J, Tempia S, Walaza S, McMorrow M, Treurnicht F, Wolter N BMC Med. 2023; 21(1):139.

PMID: 37038125 PMC: 10088270. DOI: 10.1186/s12916-023-02853-3.


The national burden of influenza-like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013-2015.

Tempia S, Moyes J, Cohen A, Walaza S, McMorrow M, Treurnicht F Influenza Other Respir Viruses. 2022; 16(3):438-451.

PMID: 35150059 PMC: 8983907. DOI: 10.1111/irv.12949.


References
1.
Pitman R, Melegaro A, Gelb D, Siddiqui M, Gay N, Edmunds W . Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect. 2006; 54(6):530-8. DOI: 10.1016/j.jinf.2006.09.017. View

2.
Simonsen L, Spreeuwenberg P, Lustig R, Taylor R, Fleming D, Kroneman M . Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013; 10(11):e1001558. PMC: 3841239. DOI: 10.1371/journal.pmed.1001558. View

3.
Simonsen L, Clarke M, Schonberger L, Arden N, Cox N, Fukuda K . Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998; 178(1):53-60. DOI: 10.1086/515616. View

4.
Moyes J, Cohen C, Pretorius M, Groome M, von Gottberg A, Wolter N . Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis. 2013; 208 Suppl 3:S217-26. DOI: 10.1093/infdis/jit479. View

5.
Nair H, Brooks W, Katz M, Roca A, Berkley J, Madhi S . Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011; 378(9807):1917-30. DOI: 10.1016/S0140-6736(11)61051-9. View